Advanced Synthetic Biology For Planet and Human Health
CB Therapeutics is leading the synthetic biology revolution for producing next-generation research molecules and animal-free ingredients. We create sustainable, innovative bio-manufacturing solutions to supply diverse industries from clinical research and nutraceuticals, to cosmetics and the food and beverage markets.
Compared to traditional methods of production, biosynthesis offers ways to reduce the environmental footprint, decrease production time.
Additionally, biosynthesis standardizes the production of high-quality psychedelics, cannabinoids, animal-free food ingredients, and much more.
Biosynthesis is a highly scalable process that has been used for several years in multiple sectors.
CB Therapeutics is trailblazing the creation of new opportunities for therapeutic solutions involving:
We use a cutting-edge proprietary yeast platform that enhances natural metabolic processes through precision fermentation to produce a variety of compounds, from small chemical analogs to bio-identical molecules that exactly match their counterparts in nature. The advantage of our approach is that it delivers pure, consistent, and reliable molecules.
In the News.
CARLSBAD, Calif., April 25, 2022 (GLOBE NEWSWIRE) — CB Therapeutics (the “Company”), a biosynthesis company focused on creating ethically-produced, environmentally-friendly products for human health, is celebrating a move to an expanded laboratory, which will serve to
increase its research compound production footprint.
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) — CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board.
SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) — CB Therapeutics, a biosynthesis company focused on creating ethical and environmentally-friendly products to improve mental health and increase healthspan, believes their partnership with atai Life Sciences will help to meet the growing unmet needs of patients with mental health conditions.
SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is happy to announce that it has been awarded two more patents for the novel methods of production of high value molecules using cutting-edge biosynthesis technologies. These patents (11,041,002B1 and 10,988,785B1) cover inventions on cellular agriculture breakthroughs for producing cannabinoids and precursors to various other compounds…
SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., the leading synthetic biology company focused on the development and biosynthetic production of existing and novel tryptamines and cannabinoids, is pleased to announce that it has closed an oversubscribed Series A funding round, filled entirely by re.Mind Capital, a fund launched by the psychedelics kingmaker, Christian Angermayer within Apeiron, his family office…
SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics Inc., has successfully refined its in-house downstream processing, allowing for 99.6% pure CBC. a rare cannabinoid molecule found in trace quantities in cannabis and hemp. Using these patent-pending techniques, CB Therapeutics is able to drive down the cost of purification in parallel with increasing the purity to over 99%, considered a major breakthrough for any type of purification process…